Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
Jul 2009 - Clin. Cancer Res.; 15(14):1078-0432 [PMID:19584156]
[Wei H] [Wang S] [Zhang D] [Hou S] [Qian W] [Li B] [Guo H] [Kou G] [He J] [Wang H] [Guo Y]

Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
May 2008 - Cancer Res.; 68(10):1538-7445 [PMID:18483270]
[Wei H] [Wang H] [Lu B] [Li B] [Hou S] [Qian W] [Fan K] [Dai J] [Zhao J] [Guo Y]